secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001510964-23-000003
Event type: litigation
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences reaches preliminary settlement of shareholder derivative action; final hearing May 15, 2023
--------------------------------------------------------------------------------

- U.S. District Court for Nevada granted preliminary approval on Feb 7, 2023 for settlement of Lamont v. Mona, Jr. (Case 2:15-cv-00481).
- Final approval hearing set for May 15, 2023 before Judge Richard F. Boulware II in Las Vegas.
- Settlement requires CV Sciences to implement corporate governance reforms within 60 days of final approval.
- Company and defendants deny any liability or wrongdoing; settlement is not an admission.
- Plaintiff's counsel may seek an award of attorney's fees; no monetary payment to shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096423000003/0001510964-23-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096423000003/cvsi-20230302.htm
  HTML page:      https://secwatch.observer/filing/0001510964-23-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer